JOURNAL OF SUBSTANCE ABUSE TREATMENT

metrics 2024

Exploring New Frontiers in Addiction Recovery

Introduction

JOURNAL OF SUBSTANCE ABUSE TREATMENT, published by Pergamon-Elsevier Science Ltd, is a leading peer-reviewed journal that spans a wide range of topics related to substance abuse and addiction treatments. With an impressive impact factor, this esteemed journal ranks in the Q1 quartile across multiple disciplines including Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, making it a vital resource for researchers and practitioners alike. Covering convergence years from 1984 to 2023, it publishes cutting-edge research that informs treatment methodologies and policy development in the field of substance abuse. With access options that adapt to both traditional and modern academic needs, the journal seeks to advance the understanding and effectiveness of substance abuse treatment through comprehensive studies and innovative approaches. Be part of a global dialogue that shapes the future of addiction treatment by engaging with the latest findings and expert analyses that help bridge the gap between research and clinical practice.

Metrics 2024

SCIMAGO Journal Rank1.52
Journal Impact Factor3.70
Journal Impact Factor (5 years)3.80
H-Index122
Journal IF Without Self3.70
Eigen Factor0.01
Normal Eigen Factor2.25
Influence1.33
Immediacy Index2.30
Cited Half Life6.60
Citing Half Life11.30
JCI1.29
Total Documents2983
WOS Total Citations7751
SCIMAGO Total Citations25281
SCIMAGO SELF Citations2315
Scopus Journal Rank1.52
Cites / Document (2 Years)3.50
Cites / Document (3 Years)3.47
Cites / Document (4 Years)3.56

Metrics History

Rank 2024

Scopus

Psychiatric Mental Health in Nursing
Rank #3/45
Percentile 93.33
Quartile Q1
Clinical Psychology in Psychology
Rank #32/311
Percentile 89.71
Quartile Q1
Medicine (miscellaneous) in Medicine
Rank #56/398
Percentile 85.93
Quartile Q1
Psychiatry and Mental Health in Medicine
Rank #86/567
Percentile 84.83
Quartile Q1

IF (Web Of Science)

PSYCHOLOGY, CLINICAL
Rank 25/180
Percentile 86.40
Quartile Q1
SUBSTANCE ABUSE
Rank 10/55
Percentile 82.70
Quartile Q1

JCI (Web Of Science)

PSYCHOLOGY, CLINICAL
Rank 22/180
Percentile 87.78
Quartile Q1
SUBSTANCE ABUSE
Rank 8/55
Percentile 85.45
Quartile Q1

Quartile History

Similar Journals

Addiction Science & Clinical Practice

Unlocking the potential of addiction science for all.
Publisher: BMCISSN: 1940-0640Frequency: 1 issue/year

Addiction Science & Clinical Practice is a premier open-access journal dedicated to advancing the understanding and treatment of addiction through evidence-based research and clinical practice. Published by BMC in the United Kingdom since 2007, this journal has significantly impacted the fields of Clinical Psychology, Medicine, and Psychiatry and Mental Health, proudly securing a Q1 ranking in multiple categories as of 2023. With an emphasis on high-quality research, the journal provides an inclusive platform for the dissemination of innovative findings and clinical insights that address the complexities of addiction. Researchers, practitioners, and students alike benefit from its unrestricted access since 2012, allowing for widespread dissemination of knowledge. Located at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to lead the way in fostering collaboration and informing best practices in addiction science.

Annals of Clinical Psychiatry

Illuminating the Path to Better Mental Health Outcomes.
Publisher: QUADRANT HEALTHCOM INCISSN: 1040-1237Frequency: 4 issues/year

Annals of Clinical Psychiatry, published by QUADRANT HEALTHCOM INC, is a leading journal in the fields of Medicine and Psychiatry & Mental Health. With its longstanding commitment to advancing clinical knowledge since 1989, this esteemed journal contributes invaluable insights into current psychiatric practices and mental health research. The journal is recognized in the Scopus ranking with a position in the 34th percentile, reflective of its focused scope and substantial academic contributions. While access to the journal is tailored for professionals and researchers, the absence of Open Access highlights the journal's dedication to maintaining quality and rigorous peer-reviewed standards. As part of the Q3 quartile for both Medicine and Psychiatry categories in 2023, Annals of Clinical Psychiatry serves as an essential resource for those dedicated to improving mental health outcomes, making it a vital platform for practitioners, researchers, and students alike. Situated in Parsippany, New Jersey, the journal remains a pivotal entity that fosters scholarly dialogue and exploration in clinical psychiatry.

Journal of Substance Use & Addiction Treatment

Unlocking insights for effective addiction strategies.
Publisher: ELSEVIER SCIENCE INCISSN: 2949-8767Frequency: 12 issues/year

Journal of Substance Use & Addiction Treatment is a premier scholarly publication dedicated to advancing the understanding and treatment of substance use disorders and addictive behaviors. Published by Elsevier Science Inc, this journal serves as a vital platform for researchers, clinicians, and students in the fields of psychology, psychiatry, public health, and addiction studies. With its commitment to Open Access, the journal facilitates wide dissemination of cutting-edge research, enabling practitioners and policymakers to access critical findings that inform treatment approaches and public health strategies. As an essential resource in addiction treatment and research, the Journal of Substance Use & Addiction Treatment aims to foster interdisciplinary collaboration and innovation, ultimately improving outcomes for individuals affected by addiction.

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Illuminating the Pathways of Recovery and Treatment
Publisher: TAYLOR & FRANCIS INCISSN: 0095-2990Frequency: 6 issues/year

American Journal of Drug and Alcohol Abuse is a highly regarded publication in the field of substance abuse research, published by Taylor & Francis Inc. With its inception in 1974, this journal has become an essential resource for scholars and practitioners interested in clinical psychology, psychiatry, and the multifaceted issues surrounding drug and alcohol use. It holds a notable Q2 ranking in Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, emphasizing its impact and relevance in these domains. The journal's 2023 Scopus rankings further highlight its standing, placing it in the top quartile of publications with established readership and citation metrics. Researchers and students can benefit from its comprehensive articles that delve into the complexities of substance use, treatment methodologies, and the socio-psychological underpinnings of addiction. Whether you seek to access cutting-edge studies or contribute to ongoing discourse in the field, the American Journal of Drug and Alcohol Abuse serves as a vital hub for knowledge dissemination and scholarly engagement.

SUBSTANCE USE & MISUSE

Unraveling the intricacies of substance use to inform policy and practice.
Publisher: TAYLOR & FRANCIS INCISSN: 1082-6084Frequency: 14 issues/year

SUBSTANCE USE & MISUSE, published by Taylor & Francis Inc, is an esteemed academic journal dedicated to the multifaceted study of substance use and its implications on health and society. With a notable impact factor and categorized in the Q2 quartile across multiple fields—including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, as well as Public Health—this journal serves as an essential platform for researchers, professionals, and students alike. Spanning from 1966 to 2024, it provides a rich archive of peer-reviewed articles that explore current trends, innovative research, and evidence-based practices in the management and understanding of substance use. The journal offers various access options, catering to the diverse needs of its audience and affirming its commitment to fostering scholarly discourse in the United Kingdom and beyond. By engaging with this journal, readers can enhance their understanding of the complexities surrounding substance use, making it a crucial resource for advancing knowledge and informing policy in this critical area of public health.

DRUG AND ALCOHOL DEPENDENCE

Innovating solutions for addiction and dependency issues.
Publisher: ELSEVIER IRELAND LTDISSN: 0376-8716Frequency: 12 issues/year

Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.

Therapeutic Communities

Elevating discourse in therapeutic community practices.
Publisher: EMERALD GROUP PUBLISHING LTDISSN: 0964-1866Frequency: 4 issues/year

Therapeutic Communities, a publication of EMERALD GROUP PUBLISHING LTD, has been a significant contributor to the fields of clinical psychology, psychiatry, and mental health since its inception in 1992. With the ISSN 0964-1866 and E-ISSN 2052-4730, this journal aims to disseminate innovative research and comprehensive reviews that advance our understanding of therapeutic communities and their impact on psychological well-being. Although currently ranked in the Q4 category for Clinical Psychology and Health Professions, the journal continues to strive towards elevating scholarly discourse and practice in mental health settings. Located in the United Kingdom, the journal does not offer open access, but its content remains vital for researchers and practitioners seeking to explore therapeutic modalities and community-based interventions. As the landscape of mental health care evolves, Therapeutic Communities stands as a crucial platform for sharing insights and fostering collaboration among professionals in this essential domain.

Substance Abuse and Rehabilitation

Exploring the complexities of substance use and rehabilitation.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-8467Frequency: 1 issue/year

Substance Abuse and Rehabilitation, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to the study and treatment of substance abuse and related rehabilitation practices. With its ISSN 1179-8467, this journal provides a vital platform for researchers, clinicians, and students to disseminate their findings and insights in a field increasingly relevant to public health. Since becoming open access in 2010, the journal has enhanced its reach, allowing for a broader audience to engage with cutting-edge research and reviews that address the complexities of substance abuse disorders. The journal aims to foster innovation and interdisciplinary collaboration by publishing high-quality peer-reviewed articles that cover a wide range of topics, including addiction therapy, policy implications, and the social determinants of substance use. As a vital resource within the realm of addiction research, Substance Abuse and Rehabilitation plays a crucial role in driving forward knowledge and practices that can improve outcomes for individuals and communities affected by substance use issues.

COMMUNITY MENTAL HEALTH JOURNAL

Fostering connections for better mental health outcomes globally.
Publisher: SPRINGERISSN: 0010-3853Frequency: 6 issues/year

Community Mental Health Journal is a leading publication in the field of mental health, managed by Springer and based in the United States. Since its inception in 1965, this journal has provided a critical platform for advancements in mental health research and community practices, with a convergence set to continue until 2024. It boasts an impressive impact factor and ranks in the first quartile (Q1) for Health (Social Science) as well as Public Health, Environmental and Occupational Health, underscoring its significance in interdisciplinary scholarship. The journal caters to a diverse audience, including researchers, practitioners, and students, fostering a deeper understanding of community mental health issues. With a commitment to highlighting innovative research and practical applications, the Community Mental Health Journal serves as an invaluable resource for those dedicated to improving mental health outcomes in communities globally.

Journal of Dual Diagnosis

Pioneering research for effective dual disorder treatments.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1550-4263Frequency: 4 issues/year

The Journal of Dual Diagnosis, published by Routledge Journals, Taylor & Francis Ltd, is a leading interdisciplinary platform dedicated to the critical study of co-occurring mental health and substance use disorders. With its ISSN 1550-4263 and E-ISSN 1550-4271, this esteemed journal has been at the forefront of advancing research and clinical practice since its inception in 2004, and continues to serve as a vital resource until 2024. Ranked in the second quartile (Q2) in Psychiatry and Mental Health and positioned at the 64th percentile in the Scopus rankings, it emphasizes the importance of integrating care across various domains of health. Although not open access, it offers a wealth of peer-reviewed articles, case studies, and reviews suitable for researchers, practitioners, and students alike, aiming to enhance our understanding and treatment of dual diagnosis. The journal's commitment to addressing the complexities of dual disorders not only informs research but also shapes policy and clinical guidelines, making it an essential read for anyone involved in these critical areas of mental health.